Related Experiment Video
Updated: May 17, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Managing Chronic Urticaria in Children: An Update
Luis Felipe Ensina1, Larissa Brandão2, Elena Netchiporouk3
1Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil. 100alergia@gmail.com.
Pediatric chronic urticaria is common and often resolves within two years. Effective treatments include H1-antihistamines, omalizumab, and potentially dupilumab, improving patient outcomes.
Area of Science:
- Pediatric Dermatology
- Allergy and Immunology
- Clinical Therapeutics
Background:
- Chronic urticaria (CU) in children presents unique diagnostic and therapeutic challenges.
- Understanding pediatric CU prevalence and natural history is crucial for effective management.
Purpose of the Study:
- To update current knowledge on pediatric chronic urticaria management.
- To provide new insights into treatment strategies and patient outcomes.
Main Methods:
- Review of recent literature on pediatric chronic urticaria.
- Analysis of treatment efficacy, including antihistamines, omalizumab, and dupilumab.
- Evaluation of patient-reported outcome measures (PROMs) in pediatric populations.
Main Results:
- Pediatric CU may be more prevalent than previously recognized, with a high spontaneous resolution rate.
- Patient-reported outcome measures (PROMs) are valuable for assessing disease severity and control.
- Children with CU often show better response to H1-antihistamines than adults.
- Omalizumab demonstrates excellent efficacy in antihistamine-refractory cases.
- Dupilumab is an emerging treatment option for chronic spontaneous urticaria.
Conclusions:
- Despite challenges, advancements in understanding disease mechanisms and novel therapies offer promise for pediatric CU.
- Improved diagnostic tools and validated outcome measures enhance treatment effectiveness.
- Personalized therapeutic approaches are key to optimizing outcomes for children with chronic urticaria.
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Allergic Reactions

